Saito Bio: Revenue directly from the US market accounted for less than 3% of the company's total revenue in 2024.

On April 15, Jin10 reported that Saito Bio stated on the interactive platform that revenue directly from the US market accounts for less than 3% of the company's total revenue in 2024. The company will actively expand into other overseas markets, flexibly adjust its business strategy, and move forward steadily.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)